InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,650.00
(
0.05%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.59
(
0.00%
)
Bitcoin
60,997.56
(
0.33%
)
Post# of 531
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Charles Living

Send PM Follow Ignore
Followers 3
Posts 429
Boards Moderated 0
Alias Born 02/12/2012

Charles Living

Re: None

Friday, 08/24/2012 9:59:57 AM

Friday, August 24, 2012 9:59:57 AM

Post# of 531
HEB (+12%) Hemispherx Biopharma files complete response with the FDA regarding its Ampligen new drug application for Chronic Fatigue Syndrome -- The FDA has agreed to accept, for review, further analyses of data from Hemispherx's AMP-516 Phase (Briefing.com)
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up